Apr 26, 2021 | Video Transcripts
Biologics by McKesson Patient Voice Spotlight – Karen I. Karen I., Biologics by McKesson Oncology Patient: I was diagnosed in June 2008 [with] stage 2C ovarian cancer. I had an MRI and a CAT Scan, and within a week, I was in a GYN oncologist’s office, and...
Apr 26, 2021 | Video Transcripts
Biologics by McKesson Patient Voice Spotlight – Larry H. Larry H., Biologics by McKesson Oncology Patient: I was diagnosed in early 2012, and the condition is Waldenstrom macroglobulinemia. It’s a bit of non-Hodgkins lymphoma, along with a couple of other...
Apr 26, 2021 | Video Transcripts
Biologics by McKesson Patient Voice Spotlight – Erica R. Erica R., Biologics by Mckesson Oncology Patient: I was diagnosed in December of 2015 with Stage 3A Ovarian Cancer. I woke up in the middle of the night with the most excruciating abdominal pain I had...
Jul 20, 2020 | Video Transcripts
Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL). Alison Duffy, PharmD, BCOP: What are your recommendations, Dr Steeves, for physicians in the community to...
Jul 17, 2020 | Video Transcripts
Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists. Alison Duffy, PharmD, BCOP: We talked a little bit about the efficacy and safety information. What characteristics of the oral therapies that we haven’t...
Jul 17, 2020 | Video Transcripts
A comparison of the safety and efficacy of orally and intravenously administered oncolytics. Alison Duffy, PharmD, BCOP: Dr Steeves, what has been your experience with efficacy and safety of the oral agents versus IV [intravenous] in terms of best practices for...
